Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
doi: https://doi.org/10.1101/2024.03.28.24304995
Maria Marchante
1Gameto Inc., New York, New York
Ferran Barrachina
1Gameto Inc., New York, New York
Sabrina Piechota
1Gameto Inc., New York, New York
Marta Fernandez-González
1Gameto Inc., New York, New York
Alexa Giovannini
1Gameto Inc., New York, New York
Trozalla Smith
2Spring Fertility, New York, New York
Simone Kats
1Gameto Inc., New York, New York
Bruna Paulsen
1Gameto Inc., New York, New York
Eva González
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
Virginia Calvente
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
Ana Silvan
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
Baruch Abittan
4Extend Fertility, New York, New York
Joshua Klein
4Extend Fertility, New York, New York
Peter Klatsky
2Spring Fertility, New York, New York
Daniel Ordonez
3Ruber Juan Bravo University Hospital, Eugin Group, Madrid, Spain
Christian C. Kramme
1Gameto Inc., New York, New York

Data Availability
Data Sharing Statement: All data needed to evaluate the conclusions in the paper are present in the paper and supplementary tables and figures.
Posted March 28, 2024.
Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
medRxiv 2024.03.28.24304995; doi: https://doi.org/10.1101/2024.03.28.24304995
Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
medRxiv 2024.03.28.24304995; doi: https://doi.org/10.1101/2024.03.28.24304995
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)